Wealth Effects’s GE HealthCare GEHC Stock Holding History

Wealth Effects’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,636	Closed	-$216K	–	246
2025 Q4	$216K	Buy	+2,636	New	+$205K	0.07%	190

Other funds holding GEHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Wealth Effects's GEHC Position: Q1 2026 in Review

Wealth Effects sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 2,636 shares — an estimated $216K sold.

Wealth Effects first reported a position in GEHC in Q4 2025 and held it in 1 quarter. The position peaked at $216K in Q4 2025. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

Wealth Effects reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
Wealth Effects sold 2,636 GE HealthCare shares in Q1 2026, an estimated $216K.
Wealth Effects first reported a position in GE HealthCare in Q4 2025 and held it in 1 quarter.
Wealth Effects's GE HealthCare position peaked at $216K in Q4 2025.
1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Wealth Effects's 13F filing for Q1 2026, filed 21 Apr 2026.